Skip to content

Comparing pain relief after hip fracture surgery using 30 ml or 40 ml ropivacaine fascia iliaca nerve block

Comparison of the efficacy of Suprainguinal fascia iliaca block with different volumes of Ropivacaine for postoperative analgesia in patients undergoing surgery for neck of femur and intertrochanteric fractures: A randomised single-blind clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113753
Enrollment
50
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: S721- Pertrochanteric fracture

Interventions

Intervention1: Ultrasound-guided suprainguinal fascia iliaca block with 40 ml Ropivacaine: Participants will receive a single preoperative suprainguinal fascia iliaca block using 40 ml of 0.25 percent

Sponsors

Dr. S.N. Medical College, Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I-III, scheduled for surgical fixation of the neck of the femur or intertrochanteric fracture, Able to provide informed consent.

Exclusion criteria

Exclusion criteria: Allergy to amide local anaesthetics. Coagulopathy or anticoagulant use where patients are unable to safely discontinue antiplatelet agents or anticoagulants. Infection at the block site. Neurological deficits affecting the limb. Body Mass Index greater than 35 kilograms per meter squared. Patient refusal.

Design outcomes

Primary

MeasureTime frame
Time from completion of suprainguinal fascia iliaca block injection to first rescue analgesia, defined as the first intravenous tramadol rescue dose given on patient request or when NRS is greater than 4, whichever occurs first.Timepoint: From completion of suprainguinal fascia iliaca block injection until first rescue analgesia or 24 hours after block injection.

Secondary

MeasureTime frame
NRS pain scores at rest and on movement, total tramadol consumption, sensory block characteristics, early motor grade, hemodynamic parameters, adverse effects and complications, obturator nerve blockade, and patient satisfaction score.Timepoint: NRS at 2, 4, 6, 8, 12, 18, and 24 hours after block. Tramadol use, adverse effects, complications, and satisfaction during the first 24 hours. Sensory and motor assessments at 5 and 10 minutes with sensory regression recorded up to 24 hours.

Countries

India

Contacts

Public ContactDr Vandana Sharma

Dr. S.N. Medical college,Jodhpur

vandana.sh02@gmail.com9460157024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026